| microRNAs in cardiovascular diseases: current knowledge and the road ahead G Condorelli, MVG Latronico, E Cavarretta Journal of the American College of Cardiology 63 (21), 2177-2187, 2014 | 439 | 2014 |
| Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy R Roncarati, C Viviani Anselmi, MA Losi, L Papa, E Cavarretta, ... Journal of the American College of Cardiology 63 (9), 920-927, 2014 | 346 | 2014 |
| Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: a scoping review F Infusino, M Marazzato, M Mancone, F Fedele, CM Mastroianni, ... Nutrients 12 (6), 1718, 2020 | 214 | 2020 |
| A 20-year experience with mitral valve repair with artificial chordae in 608 patients L Salvador, S Mirone, R Bianchini, T Regesta, F Patelli, G Minniti, ... The Journal of thoracic and cardiovascular surgery 135 (6), 1280-1287. e1, 2008 | 198 | 2008 |
| Acute effects of Heat‐Not‐Burn, electronic Vaping, and traditional tobacco combustion cigarettes: the Sapienza University of Rome‐Vascular assessment of proatherosclerotic … G Biondi‐Zoccai, S Sciarretta, C Bullen, C Nocella, F Violi, L Loffredo, ... Journal of the American Heart Association 8 (6), e010455, 2019 | 167 | 2019 |
| Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study S De Castro, S Caselli, M Maron, A Pelliccia, E Cavarretta, P Maddukuri, ... Heart 93 (2), 205-209, 2007 | 102 | 2007 |
| Impairment between oxidant and antioxidant systems: short-and long-term implications for athletes’ health C Nocella, V Cammisotto, F Pigozzi, P Borrione, C Fossati, A D’Amico, ... Nutrients 11 (6), 1353, 2019 | 90 | 2019 |
| Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise … PE Adami, N Koutlianos, A Baggish, S Bermon, E Cavarretta, ... European Journal of Preventive Cardiology 29 (3), 559-575, 2022 | 76* | 2022 |
| SARS-CoV-2 and COVID-19. Facing the pandemic together as citizens and cardiovascular practitioners G Biondi-Zoccai, G Landoni, R Carnevale, E Cavarretta, S Sciarretta, ... Minerva cardioangiologica 68 (2), 61-64, 2020 | 60 | 2020 |
| Deregulation of Notch1 pathway and circulating endothelial progenitor cell (EPC) number in patients with bicuspid aortic valve with and without ascending aorta aneurysm CR Balistreri, F Crapanzano, L Schirone, A Allegra, C Pisano, G Ruvolo, ... Scientific reports 8 (1), 13834, 2018 | 59 | 2018 |
| Remodelling of the left ventricle in athlete’s heart: a three dimensional echocardiographic and magnetic resonance imaging study S De Castro, A Pelliccia, S Caselli, ED Angelantonio, F Papetti, ... Heart 92 (7), 975-976, 2006 | 53 | 2006 |
| Cardiac remodeling in obese patients after laparoscopic sleeve gastrectomy E Cavarretta, G Casella, B Calì, C Dammaro, G Biondi-Zoccai, A Iossa, ... World journal of surgery 37, 565-572, 2013 | 52 | 2013 |
| Echocardiographic findings in 2261 peri-pubertal athletes with or without inverted T waves at electrocardiogram L Calò, F Sperandii, A Martino, E Guerra, E Cavarretta, F Quaranta, ... Heart 101 (3), 193-200, 2015 | 51 | 2015 |
| Morphological and chemical study of pathological deposits in human aortic and mitral valve stenosis: a biomineralogical contribution V Cottignoli, E Cavarretta, L Salvador, C Valfré, A Maras Pathology Research International 2015, 2015 | 51 | 2015 |
| Usefulness of tricuspid annular velocity in identifying global RV dysfunction in patients with primary pulmonary hypertension: a comparison with 3D echo‐derived right … S De Castro, E Cavarretta, A Milan, S Caselli, E Di Angelantonio, ... Echocardiography 25 (3), 289-293, 2008 | 50 | 2008 |
| Pathological biominerals: Raman and infrared studies of bioapatite deposits in human heart valves S Mangialardo, V Cottignoli, E Cavarretta, L Salvador, P Postorino, ... Applied Spectroscopy 66 (10), 1121-1127, 2012 | 49 | 2012 |
| Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience. AG Marullo, E Cavarretta, G Biondi Zoccai, M Mancone, M Peruzzi, ... Minerva Cardioangiol, 368-372, 2020 | 48 | 2020 |
| miR-21 and cardiac fibrosis: another brick in the wall? E Cavarretta, G Condorelli European heart journal 36 (32), 2139-2141, 2015 | 47 | 2015 |
| The role of antioxidants supplementation in clinical practice: focus on cardiovascular risk factors V Cammisotto, C Nocella, S Bartimoccia, V Sanguigni, D Francomano, ... Antioxidants 10 (2), 146, 2021 | 46 | 2021 |
| MicroRNAs in coronary heart disease: ready to enter the clinical arena? E Cavarretta, G Frati BioMed Research International 2016, 2016 | 46 | 2016 |
Giacomo FratiProfessore Ordinario, Università "Sapienza",RomaVerified email at uniroma1.it
